Transient postprandial increase in intact circulating fibroblast growth factor-21 levels after Roux-en-Y gastric bypass: a randomized controlled clinical trial

Transient postprandial increase in intact circulating fibroblast growth factor-21 levels after Roux-en-Y gastric bypass: a randomized controlled clinical trial

Background Despite a consistent link between obesity and increased circulating levels of fibroblast growth factor-21 (FGF21), the effect of weight-loss interventions on FGF21 is not clear. We aimed to determine the short- and long-term effects of Roux-en-Y gastric bypass (RYGB) on intact plasma FGF2...

Full description

Bibliographic Details
Main Authors: Mette S. Nielsen, Susanna Søberg, Julie B. Schmidt, Anne Chenchar, Anders Sjödin, Matthew P. Gillum
Format: Article
Language:English
Published: PeerJ Inc. 2021-04-01
Series:PeerJ
Subjects:
Fibroblast growth factor-21
Bariatric surgery
Randomized controlled trial
Diet-induced weight loss
Weight loss
Online Access:https://peerj.com/articles/11174.pdf

Internet

https://peerj.com/articles/11174.pdf

Similar Items